Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Costco Wholesale Corporation Reports Third Quarter and Year-to-Date Operating Results for Fiscal 2024
-
LXP Industrial Trust Announces Beth Boulerice to Step Down as Chief Financial Officer and be Succeeded by Nathan Brunner
-
Tecnoglass to Attend Upcoming Investor Conferences
-
Vertex to Present at Upcoming Conferences
-
Dentsply Sirona to Participate in Upcoming Investor Conferences
-
CooperCompanies Announces Second Quarter 2024 Results
-
Asure Releases 2024 HR Benchmark Report and Survey Results
-
LED Lighting, EV Charging and Maintenance Solutions Provider Orion Hosts Q4 Call Thurs., June 6th at 10am ET
-
Caring House Receives $3 Million Challenge Grant for Expansion of Durham Hospitality House
-
Landsbankinn hf.: Contract providing for Landsbankinn’s purchase of TM concluded
-
Park Aerospace Corp. Reports Fourth Quarter and Fiscal Year Results
-
Collective Audience Receives Additional Nasdaq Notification Regarding Continued Listing Requirements
-
Kimco Realty® Management to Present at Nareit’s REITweek: 2024 Investor Conference
-
GameStop Announces Release Date for First Quarter Fiscal 2024 Results
-
Ibotta Reports First Quarter 2024 Financial Results
-
Zscaler Reports Third Quarter Fiscal 2024 Financial Results
-
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
-
Highwoods to Present at Nareit’s REITweek: 2024 Investor Conference
-
Barfresh to Participate in the Spring MicroCap Rodeo Conference
-
Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
-
Ambarella, Inc. Announces First Quarter Fiscal Year 2025 Financial Results
-
Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
-
Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedreich’s Ataxia
-
IndyCar Driver Marcus Armstrong to Represent Root Insurance at Detroit Grand Prix
-
Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension
-
Health Catalyst to Participate in Upcoming Investor Conferences
-
nCino to Participate in Upcoming Investor Event
-
Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affairs
-
BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Aura Biosciences to Participate in the Jefferies Global Healthcare Conference
-
NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
-
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
-
PATH (NYSE) INVESTIGATION ALERT: BFA Law Announces Investigation into UiPath, Inc., Encourages Investors to Inquire and Learn More After Stock Tumbles Over 34%
-
Ardelyx, Inc. Reports Employment Inducement Grants
-
Corvus Pharmaceuticals to Present at the Jefferies Global Health Conference
-
GDMining Expands Global Reach - Offers New Mining Facilities and New Contracts Opportunities
-
Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences
-
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential fut
-
Korro to Participate in Upcoming June Investor and Scientific Conferences
-
Verve Therapeutics to Participate in Upcoming Investor Conferences
-
Lands’ End Rings Nasdaq Opening Bell to Celebrate 10th Anniversary of its Listing on the Exchange
-
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future
-
Ultragenyx Announces Positive Top-Line Results from Phase 3 Study of DTX401 Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
-
Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination
-
Highest Performances Holdings Inc. Announces Unaudited Financial Results for the First Half of the Fiscal Year 2024
-
Immunocore to present at the Jefferies Global Healthcare Conference
-
Congratulating Cayuse’s Latest Live Customers
-
Coffee With Q Announces Exclusive Interview with Brand Featured CEO David Varnai
-
Starting today, Verizon offers new and existing customers iPhone 15, on us, for the first time ever
-
Restaurants Canada Serves Up Recognition

